Bio-Rad Debt To Equity from 2010 to 2024

BIO-B Stock  USD 334.85  38.50  10.31%   
Bio-Rad Laboratories' Debt To Equity is decreasing over the years with slightly volatile fluctuation. Debt To Equity is expected to dwindle to 0.13. Debt To Equity is a measure of a company's financial leverage calculated by dividing its total liabilities by stockholders' equity, indicating the proportion of equity and debt the company is using to finance its assets. View All Fundamentals
 
Debt To Equity  
First Reported
2010-12-31
Previous Quarter
0.13613087
Current Value
0.13
Quarterly Volatility
0.20665057
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Bio-Rad Laboratories financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bio-Rad Laboratories' main balance sheet or income statement drivers, such as Depreciation And Amortization of 202 M, Interest Expense of 51.9 M or Selling General Administrative of 475.9 M, as well as many indicators such as Price To Sales Ratio of 3.71, Dividend Yield of 0.0 or PTB Ratio of 2.15. Bio-Rad financial statements analysis is a perfect complement when working with Bio-Rad Laboratories Valuation or Volatility modules.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Bio Rad Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bio-Rad Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Rad Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Rad Laboratories Stock:
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Please note, there is a significant difference between Bio-Rad Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio-Rad Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio-Rad Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.